Skip to main content
. 2023 Sep 5;13:1200625. doi: 10.3389/fonc.2023.1200625

Table 6.

Relationship between the PD-L1 expression and the rate of pathological remission after different cycles of treatment.

PD-L1 expression (TPS) Number of Neoadjuvant therapy cycles (%) P value
2 (n=35) 3-4 (n=31)
≤ 10% n=21 n=16 0.041
 MPR 2 (9.5) 6 (37.5)
 Non-MPR 19 (90.5) 10 (62.5)
> 10% n=14 n=15 0.518
 MPR 10 (71.4) 9 (60.0)
 Non-MPR 4 (28.6) 6 (40.0)

MPR, major pathological response; TPS, tumor proportion score (PD-L1 expression).